acetylcysteine has been researched along with MPTP Neurotoxicity Syndrome in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biswas, S; Dutta, AK; Le, W; Li, C; Li, X | 1 |
| Ali, SF; Bains, M; Clark, RA; Imam, SZ; Kahle, PJ; Li, S; Roberts, JL; Valente, AJ; Yamamoto, A; Zhou, Q | 1 |
| Baek, SY; Chung, BS; Kang, CD; Kim, JY; Kim, SD; Kim, SH; Park, KH; Park, SW | 1 |
| Grünblatt, E; Mandel, S; Youdim, MB | 1 |
| Agarwal, V; Diwakar, L; Iyengar, S; Karunakaran, S; Ramakrishnan, S; Ravindranath, V; Saeed, U | 1 |
| Gill, KD; Kaur, P; Kumar, V; Sharma, A | 1 |
| Aoyama, K; Matsumura, N; Nakaki, T; Watabe, M | 1 |
7 other study(ies) available for acetylcysteine and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
Novel D3 dopamine receptor-preferring agonist D-264: Evidence of neuroprotective property in Parkinson's disease animal models induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and lactacystin.
Topics: Acetylcysteine; Animals; Benzothiazoles; Biphenyl Compounds; Brain; Brain Chemistry; Brain-Derived Neurotrophic Factor; Cysteine Proteinase Inhibitors; Dopamine Agonists; Dopamine Antagonists; Enzyme-Linked Immunosorbent Assay; Glial Cell Line-Derived Neurotrophic Factor; Immunohistochemistry; Indans; Locomotion; Male; Mice; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; Neostriatum; Neuroprotective Agents; Parkinson Disease, Secondary; Piperazines; Postural Balance; Proteasome Endopeptidase Complex; Receptors, Dopamine D3; Thiazoles | 2010 |
Novel regulation of parkin function through c-Abl-mediated tyrosine phosphorylation: implications for Parkinson's disease.
Topics: Acetylcysteine; Animals; Benzamides; Brain; Case-Control Studies; Cell Line; Disease Models, Animal; Dopamine; Drug Administration Schedule; Free Radical Scavengers; Gene Expression Regulation; Green Fluorescent Proteins; Humans; Imatinib Mesylate; Immunoprecipitation; Male; Metalloporphyrins; Mice; Mice, Inbred C57BL; MPTP Poisoning; Oxidative Stress; Peptide Elongation Factors; Phosphorylation; Piperazines; Polyethylene Glycols; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-abl; Pyrimidines; RNA, Small Interfering; Statistics, Nonparametric; Transfection; Tumor Suppressor Proteins; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination | 2011 |
Preventive effect of antioxidants in MPTP-induced mouse model of Parkinson's disease.
Topics: Acetylcysteine; Analysis of Variance; Animals; Antioxidants; Blotting, Western; Brain; Cell Count; Cell Death; Disease Models, Animal; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Immunohistochemistry; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; MPTP Poisoning; PC12 Cells; Pyrrolidonecarboxylic Acid; Rats; Thiazoles; Thiazolidines; Time Factors; Tyrosine 3-Monooxygenase | 2004 |
The copper chelator, D-penicillamine, does not attenuate MPTP induced dopamine depletion in mice.
Topics: Acetylcysteine; Animals; Chelating Agents; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dopamine Agents; Iron; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Nerve Degeneration; Neuroprotective Agents; Penicillamine; Salicylic Acid | 2007 |
Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by alpha-lipoic acid.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acetylcysteine; Alkynes; Animals; Antioxidants; Antiparkinson Agents; Biotransformation; Carrier Proteins; Cell Nucleus; Co-Repressor Proteins; Cystathionine gamma-Lyase; Cytosol; Dopamine; Drug Evaluation, Preclinical; Electron Transport Complex I; Enzyme Activation; Glutathione; Glycine; Intracellular Signaling Peptides and Proteins; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Kinase 4; MAP Kinase Kinase Kinase 5; MAP Kinase Signaling System; Mesencephalon; Mice; Mice, Inbred C57BL; Molecular Chaperones; MPTP Poisoning; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Nuclear Proteins; Oncogene Proteins; Parkinsonian Disorders; Peroxiredoxins; Phosphorylation; Protein Deglycase DJ-1; Protein Processing, Post-Translational; Protein Transport; Substantia Nigra; Thioctic Acid | 2007 |
Attenuation of 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine induced nigrostriatal toxicity in mice by N-acetyl cysteine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acetylcysteine; Animals; Antioxidants; Corpus Striatum; Dopamine; Dopamine Agents; gamma-Glutamyltransferase; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Humans; Lipid Peroxidation; Mice; Mice, Inbred C57BL; Middle Aged; MPTP Poisoning; Neurotoxins; Substantia Nigra; Sulfhydryl Compounds; Superoxide Dismutase | 2007 |
Oxidative stress on EAAC1 is involved in MPTP-induced glutathione depletion and motor dysfunction.
Topics: 1-Methyl-4-phenylpyridinium; Acetylcysteine; Animals; Aspartic Acid; Behavior, Animal; Cysteine; Disease Models, Animal; Drug Interactions; Excitatory Amino Acid Transporter 1; Free Radical Scavengers; Glutathione; Humans; Hydrogen Peroxide; Hydroxamic Acids; In Vitro Techniques; Indazoles; Male; Mice; Mice, Inbred C57BL; Movement Disorders; MPTP Poisoning; Neuroprotective Agents; Oxidative Stress; Substantia Nigra | 2008 |